{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T10:10:57Z","timestamp":1775211057368,"version":"3.50.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100013521","name":"Cosmetic Surgery Foundation","doi-asserted-by":"publisher","award":["16,23"],"award-info":[{"award-number":["16,23"]}],"id":[{"id":"10.13039\/100013521","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013521","name":"Cosmetic Surgery Foundation","doi-asserted-by":"publisher","award":["16,20"],"award-info":[{"award-number":["16,20"]}],"id":[{"id":"10.13039\/100013521","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.berh.2024.101987","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T23:40:21Z","timestamp":1726616421000},"page":"101987","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Challenges and complications in juvenile localized scleroderma: A practical approach"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4965-3259","authenticated-orcid":false,"given":"Clare E.","family":"Pain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn S.","family":"Torok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2024.101987_bib1","article-title":"The prevalence of localised scleroderma in childhood assessed in the administrative claims data from the United States","volume":"I-2","author":"Beukelman","year":"2018","journal-title":"Journal of Scleroderma and Related Disorders"},{"issue":"2","key":"10.1016\/j.berh.2024.101987_bib2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/acr.20070","article-title":"Incidence of childhood linear scleroderma and systemic sclerosis in the UK and Ireland","volume":"62","author":"Herrick","year":"2010","journal-title":"Arthritis Care Res"},{"issue":"4","key":"10.1016\/j.berh.2024.101987_bib3","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.rdc.2021.07.014","article-title":"Juvenile localized scleroderma: updates and differences from adult-onset disease","volume":"47","author":"Vasquez-Canizares","year":"2021","journal-title":"Rheum Dis Clin N Am"},{"issue":"12","key":"10.1016\/j.berh.2024.101987_bib4","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1093\/rheumatology\/keab238","article-title":"Extracutaneous involvement is common and associated with prolonged disease activity and greater impact in juvenile localized scleroderma","volume":"60","author":"Li","year":"2021","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.berh.2024.101987_bib5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12969-018-0295-0","article-title":"Multi-centre national audit of juvenile localised scleroderma: describing current UK practice in disease assessment and management","volume":"16","author":"Lythgoe","year":"2018","journal-title":"Pediatr Rheumatol Online J"},{"issue":"9","key":"10.1016\/j.berh.2024.101987_bib6","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1002\/art.21264","article-title":"Localized scleroderma in childhood is not just a skin disease","volume":"52","author":"Zulian","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.berh.2024.101987_bib7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jaad.2008.05.005","article-title":"Pediatric morphea (localized scleroderma): review of 136 patients","volume":"59","author":"Christen-Zaech","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.berh.2024.101987_bib8","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archdermatol.2009.79","article-title":"Distinct autoimmune syndromes in morphea: a review of 245 adult and pediatric cases","volume":"145","author":"Leitenberger","year":"2009","journal-title":"Arch Dermatol"},{"issue":"7","key":"10.1016\/j.berh.2024.101987_bib9","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00431-018-3144-8","article-title":"Development of minimum standards of care for juvenile localized scleroderma","volume":"177","author":"Constantin","year":"2018","journal-title":"Eur J Pediatr"},{"issue":"8","key":"10.1016\/j.berh.2024.101987_bib10","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1136\/annrheumdis-2018-214697","article-title":"Consensus-based recommendations for the management of juvenile localised scleroderma","volume":"78","author":"Zulian","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.berh.2024.101987_bib11","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/acr.25281","article-title":"Capturing the range of disease involvement in localized scleroderma: the localized scleroderma total severity scale","volume":"76","author":"Li","year":"2024","journal-title":"Arthritis Care Res"},{"issue":"4","key":"10.1016\/j.berh.2024.101987_bib12","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/bjd.18879","article-title":"Exploring the impact of paediatric localized scleroderma on health-related quality of life: focus groups with youth and caregivers","volume":"183","author":"Zigler","year":"2020","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.berh.2024.101987_bib13","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/bjd.18512","article-title":"A novel patient-reported outcome for paediatric localized scleroderma: a qualitative assessment of content validity","volume":"182","author":"Zigler","year":"2020","journal-title":"Br J Dermatol"},{"issue":"7","key":"10.1016\/j.berh.2024.101987_bib14","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/jdv.19059","article-title":"Cross-sectional quantitative validation of the paediatric Localized Scleroderma Quality of Life Instrument (LoSQI): a disease-specific patient-reported outcome measure","volume":"37","author":"Zigler","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"Suppl1","key":"10.1016\/j.berh.2024.101987_bib15","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.5152\/eurjrheum.2019.19183","article-title":"Linear Scleroderma of the Head - Updates in management of Parry Romberg Syndrome and En coup de sabre: A rapid scoping review across subspecialties","volume":"7","author":"Glaser","year":"2020","journal-title":"Eur J Rheumatol"},{"issue":"11","key":"10.1016\/j.berh.2024.101987_bib16","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1177\/0883073820931253","article-title":"Unilateral Neuroimaging Findings in Pediatric Craniofacial Scleroderma: Parry-Romberg Syndrome and En Coup de Sabre","volume":"35","author":"Seese","year":"2020","journal-title":"J Child Neurol"},{"issue":"1","key":"10.1016\/j.berh.2024.101987_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3174\/ajnr.A0786","article-title":"Susceptibility-weighted MR imaging: a review of clinical applications in children","volume":"29","author":"Tong","year":"2008","journal-title":"AJNR Am J Neuroradiol"},{"issue":"3","key":"10.1016\/j.berh.2024.101987_bib18","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/jnnp.70.3.382","article-title":"Scleroderma \"en coup de sabre\": pathological evidence of intracerebral inflammation","volume":"70","author":"Stone","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.berh.2024.101987_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11926-009-0015-3","article-title":"Is scleroderma a vasculopathy?","volume":"11","author":"Fleming","year":"2009","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"10.1016\/j.berh.2024.101987_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s44162-024-00027-0","article-title":"Neuropathologic findings in a patient with Parry-Romberg syndrome: active cerebral vasculitis and brain injury","volume":"3","author":"Wappler-Guzzetta","year":"2024","journal-title":"Journal of Rare Diseases"},{"key":"10.1016\/j.berh.2024.101987_bib21","doi-asserted-by":"crossref","first-page":"908","DOI":"10.3389\/fimmu.2019.00908","article-title":"Immunopathogenesis of pediatric localized scleroderma","volume":"10","author":"Torok","year":"2019","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.berh.2024.101987_bib22","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/pde.12001","article-title":"A significant proportion of children with morphea en coup de sabre and Parry-Romberg syndrome have neuroimaging findings","volume":"29","author":"Chiu","year":"2012","journal-title":"Pediatr Dermatol"},{"issue":"Pt A","key":"10.1016\/j.berh.2024.101987_bib23","article-title":"Epilepsy in Parry-Romberg syndrome and linear scleroderma en coup de sabre: Case series and systematic review including 140 patients","volume":"121","author":"Hixon","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.berh.2024.101987_bib24","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.78.1_MeetingAbstracts.P01.080","article-title":"Favorable response to Rituximab supports an autoimmune mediated pathogenesis in parry-romberg syndrome (P01.080)","volume":"78","author":"Elbadawi","year":"2012","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.berh.2024.101987_bib25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.semarthrit.2015.02.008","article-title":"Mycophenolate mofetil in primary central nervous system vasculitis","volume":"45","author":"Salvarani","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2024.101987_bib26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1742-2094-9-89","article-title":"Time dependent neuroprotection of mycophenolate mofetil: effects on temporal dynamics in glial proliferation, apoptosis, and scar formation","volume":"9","author":"Ebrahimi","year":"2012","journal-title":"J Neuroinflammation"},{"issue":"11","key":"10.1016\/j.berh.2024.101987_bib27","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/rheumatology\/kep244","article-title":"Successful treatment of severe or methotrexate-resistant juvenile localized scleroderma with mycophenolate mofetil","volume":"48","author":"Martini","year":"2009","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.berh.2024.101987_bib28","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13023-019-1015-7","article-title":"Linear scleroderma \"en coup de sabre\" with extensive brain involvement-Clinicopathologic correlations and response to anti-Interleukin-6 therapy","volume":"14","author":"Magro","year":"2019","journal-title":"Orphanet J Rare Dis"},{"issue":"5 Pt 1","key":"10.1016\/j.berh.2024.101987_bib29","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.reuma.2018.05.001","article-title":"Scleroderma \"en coup de sabre\" With Epilepsy and Uveitis Successfully Treated With Tocilizumab","volume":"16","author":"Osminina","year":"2020","journal-title":"Reumatol Cl\u00ednica"},{"issue":"2","key":"10.1016\/j.berh.2024.101987_bib30","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jaad.2013.02.007","article-title":"The Localized Scleroderma Cutaneous Assessment Tool: responsiveness to change in a pediatric clinical population","volume":"69","author":"Kelsey","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.berh.2024.101987_bib31","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/bjd.18097","article-title":"Using the Localized Scleroderma Cutaneous Assessment Tool (LoSCAT) to classify morphoea by severity and identify clinically significant change","volume":"182","author":"Teske","year":"2020","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.berh.2024.101987_bib32","doi-asserted-by":"crossref","DOI":"10.1097\/PRS.0000000000009355","article-title":"Evolution of the coleman technique","volume":"150","author":"Egro","year":"2022","journal-title":"Plast Reconstr Surg"},{"issue":"4","key":"10.1016\/j.berh.2024.101987_bib33","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s00247-016-3765-x","article-title":"Musculoskeletal MRI findings of juvenile localized scleroderma","volume":"47","author":"Eutsler","year":"2017","journal-title":"Pediatr Radiol"},{"issue":"5","key":"10.1016\/j.berh.2024.101987_bib34","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3928\/01913913-20070901-12","article-title":"Orbital myositis in a child with linear scleroderma en coup de sabre","volume":"44","author":"Roulez","year":"2007","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"10","key":"10.1016\/j.berh.2024.101987_bib35","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1136\/bjo.2007.116038","article-title":"Ocular involvement in children with localised scleroderma: a multi-centre study","volume":"91","author":"Zannin","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.berh.2024.101987_bib36","series-title":"Incidence and categorization of maxillofacial MRI findings in craniofacial scleroderma","year":"2024"},{"issue":"suppl 9","key":"10.1016\/j.berh.2024.101987_bib37","article-title":"Maxillofacial MRI augments detection of non-CNS abnormalities in pediatric craniofacial scleroderma","volume":"75","author":"Glaser","year":"2023","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"10.1016\/j.berh.2024.101987_bib38","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1177\/10556656221086174","article-title":"Dental anomalies in parry-romberg syndrome: a 40-year retrospective review","volume":"60","author":"Aram","year":"2023","journal-title":"Cleft Palate Craniofac J"},{"issue":"1","key":"10.1016\/j.berh.2024.101987_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12969-017-0218-5","article-title":"Cone beam computed tomography for the assessment of linear scleroderma of the face","volume":"16","author":"Di Giovanni","year":"2018","journal-title":"Pediatr Rheumatol Online J."},{"issue":"3","key":"10.1016\/j.berh.2024.101987_bib40","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1097\/SCS.0b013e31820fe339","article-title":"Orthopedic and orthodontic treatment of Parry-Romberg syndrome","volume":"22","author":"You","year":"2011","journal-title":"J Craniofac Surg"},{"issue":"4","key":"10.1016\/j.berh.2024.101987_bib41","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s40368-019-00427-7","article-title":"Localised scleroderma en coup de sabre affecting the skin, dentition and bone tissue within craniofacial neural crest fields. Clinical and radiographic study of six patients","volume":"20","author":"Lauesen","year":"2019","journal-title":"Eur Arch Paediatr Dent"},{"issue":"1","key":"10.1016\/j.berh.2024.101987_bib42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/ICB.0000000000000381","article-title":"Bilateral choroidal excavation in juvenile localized scleroderma","volume":"12","author":"Franklin","year":"2018","journal-title":"Retin Cases Brief Rep"},{"issue":"3","key":"10.1016\/j.berh.2024.101987_bib43","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jaapos.2016.12.004","article-title":"Craniofacial linear scleroderma associated with retinal telangiectasia and exudative retinal detachment","volume":"21","author":"Lenassi","year":"2017","journal-title":"J AAPOS"},{"issue":"suppl 9","key":"10.1016\/j.berh.2024.101987_bib44","article-title":"Pediatric craniofacial scleroderma: assessing handheld 3D stereophotogrammetric imaging feasibility and reliability","volume":"73","author":"Glaser","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2024.101987_bib45","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jdcr.2022.05.038","article-title":"Pilot use of 3-dimensional photography to aid clinical decision-making in craniofacial morphea","volume":"25","author":"Ganske","year":"2022","journal-title":"JAAD Case Rep"},{"issue":"3","key":"10.1016\/j.berh.2024.101987_bib46","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ijom.2008.12.009","article-title":"Evaluation of reproducibility and reliability of 3D soft tissue analysis using 3D stereophotogrammetry","volume":"38","author":"Plooij","year":"2009","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"0","key":"10.1016\/j.berh.2024.101987_bib47","article-title":"Evaluation of autologous fat grafting in the treatment of juvenile localized scleroderma with facial involvement","volume":"0","author":"Sander","year":"2024","journal-title":"Journal of Scleroderma and Related Disorders."},{"issue":"5","key":"10.1016\/j.berh.2024.101987_bib48","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/SAP.0000000000001934","article-title":"Isolated fat grafting for reconstruction of lower face volumetric asymmetry in skeletally immature patients: a clinical outcome study","volume":"83","author":"Denadai","year":"2019","journal-title":"Ann Plast Surg"},{"issue":"3","key":"10.1016\/j.berh.2024.101987_bib49","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/SAP.0b013e31827aeb0d","article-title":"Parry-Romberg reconstruction: beneficial results despite poorer fat take","volume":"73","author":"Slack","year":"2014","journal-title":"Ann Plast Surg"},{"issue":"3","key":"10.1016\/j.berh.2024.101987_bib50","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/SCS.0000000000000831","article-title":"Esthetic restoration in progressive hemifacial atrophy (Romberg disease): structural fat grafting versus local\/free flaps","volume":"25","author":"Agostini","year":"2014","journal-title":"J Craniofac Surg"},{"issue":"7","key":"10.1016\/j.berh.2024.101987_bib51","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/acr.23101","article-title":"Predictors of longitudinal quality of life in juvenile localized scleroderma","volume":"69","author":"Ardalan","year":"2017","journal-title":"Arthritis Care Res"},{"issue":"8","key":"10.1016\/j.berh.2024.101987_bib52","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.3899\/jrheum.190311","article-title":"Initial results from a pilot comparative effectiveness study of 3 methotrexate-based consensus treatment plans for juvenile localized scleroderma","volume":"47","author":"Li","year":"2020","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2024.101987_bib53","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/acr2.1019","article-title":"Baseline description of the juvenile localized scleroderma subgroup from the childhood arthritis and rheumatology research alliance legacy registry","volume":"1","author":"Wu","year":"2019","journal-title":"ACR Open Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2024.101987_bib54","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/pde.13336","article-title":"Orthopedic complications of linear morphea: implications for early interdisciplinary care","volume":"35","author":"Schoch","year":"2018","journal-title":"Pediatr Dermatol"},{"issue":"10","key":"10.1016\/j.berh.2024.101987_bib55","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.jid.2023.04.010","article-title":"Clinical characteristics associated with musculoskeletal extracutaneous manifestations in pediatric and adult morphea: a prospective, cohort study","volume":"143","author":"Chen","year":"2023","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.berh.2024.101987_bib56","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/ddg.12724","article-title":"German guidelines for the diagnosis and therapy of localized scleroderma","volume":"14","author":"Kreuter","year":"2016","journal-title":"J Dtsch Dermatol Ges"},{"issue":"5","key":"10.1016\/j.berh.2024.101987_bib57","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/SAP.0000000000002887","article-title":"Flap reconstruction for treatment of pediatric linear scleroderma","volume":"87","author":"Yan","year":"2021","journal-title":"Ann Plast Surg"},{"issue":"2","key":"10.1016\/j.berh.2024.101987_bib58","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/01241398-200003000-00024","article-title":"Free tissue transfer in the treatment of linear scleroderma","volume":"20","author":"Katarincic","year":"2000","journal-title":"J Pediatr Orthop"},{"issue":"4","key":"10.1016\/j.berh.2024.101987_bib59","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00000637-200110000-00021","article-title":"Severe wrist contracture in a child with linear scleroderma","volume":"47","author":"Lyle","year":"2001","journal-title":"Ann Plast Surg"},{"issue":"5","key":"10.1016\/j.berh.2024.101987_bib60","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/pde.12169","article-title":"Linear morphea and leg length discrepancy: treatment with a leg-lengthening procedure","volume":"30","author":"Handler","year":"2013","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"10.1016\/j.berh.2024.101987_bib61","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/01241398-199311000-00020","article-title":"Focal scleroderma in children: an orthopaedic perspective","volume":"13","author":"Buckley","year":"1993","journal-title":"J Pediatr Orthop"},{"issue":"6","key":"10.1016\/j.berh.2024.101987_bib62","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/rheumatology\/kew479","article-title":"BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs","volume":"56","author":"Ledingham","year":"2017","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.berh.2024.101987_bib63","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/rheumatology\/key207","article-title":"The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis-Executive summary","volume":"58","author":"Holroyd","year":"2019","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.berh.2024.101987_bib64","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00007632-198601000-00021","article-title":"Scoliosis and morphea","volume":"11","author":"Burke","year":"1986","journal-title":"Spine"},{"key":"10.1016\/j.berh.2024.101987_bib65","first-page":"66","article-title":"Linear scleroderma with bilateral lesions, contractures and kyphoscoliosis","volume":"63","author":"Dave","year":"1997","journal-title":"Indian J Dermatol, Venereol Leprol"},{"issue":"8","key":"10.1016\/j.berh.2024.101987_bib66","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1002\/sctm.20-0419","article-title":"A pilot study on ex vivo expanded autologous adipose-derived stem cells of improving fat retention in localized scleroderma patients","volume":"10","author":"Wang","year":"2021","journal-title":"Stem Cells Transl Med"},{"issue":"1","key":"10.1016\/j.berh.2024.101987_bib67","first-page":"97","article-title":"Adipose-derived stem cells attenuate skin fibrosis and improve fat retention of a localized scleroderma mouse model","volume":"151","author":"Wang","year":"2023","journal-title":"Plast Reconstr Surg"},{"issue":"6","key":"10.1016\/j.berh.2024.101987_bib68","doi-asserted-by":"crossref","first-page":"704","DOI":"10.5021\/ad.2018.30.6.704","article-title":"Parry-romberg syndrome augmented by hyaluronic acid filler","volume":"30","author":"Jo","year":"2018","journal-title":"Ann Dermatol"},{"issue":"12","key":"10.1016\/j.berh.2024.101987_bib69","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.3899\/jrheum.081284","article-title":"The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures","volume":"36","author":"Arkachaisri","year":"2009","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2024.101987_bib70","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/rheumatology\/kep361","article-title":"Development and initial validation of the localized scleroderma skin damage index and physician global assessment of disease damage: a proof-of-concept study","volume":"49","author":"Arkachaisri","year":"2010","journal-title":"Rheumatology"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694224000585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694224000585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T03:34:11Z","timestamp":1727148851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694224000585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":70,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1521694224000585"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2024.101987","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges and complications in juvenile localized scleroderma: A practical approach","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2024.101987","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101987"}}